...Replimune’s stock dipped $0.61 to $20.61 Thursday. Other companies raising follow-on capital this week include Kezar Life Sciences Inc....
...Eaton, Staff Writer Moderna Inc. Guardant Health Inc. Allogene Therapeutics Inc. Catalent Inc. ChemoCentryx Inc. Fate Therapeutics Inc. CareDx Inc. Retrophin Inc. Replimune Group Inc. Kezar Life Sciences Inc. Mustang...

...Schoene was president and CEO of Elevance Renewable Sciences Inc. Cancer and autoimmune disease company Kezar Life Sciences Inc....
...Sawka, BioCentury Staff GenMark Diagnostics Inc. SutroVax Inc. Illumina Inc. Arrowhead Pharmaceuticals Inc. Tessa Therapeutics Pte. Ltd. Impel NeuroPharma Inc. Codexis Inc. Imara Inc. Kezar Life Sciences Inc....

...through the sale of 27.8 million shares at $3.25, while cancer and autoimmune disease company Kezar Life Sciences Inc....

...Transporters identified in new targets that were not related to metabolism were SEC61 and IPO1. Kezar Life Sciences Inc....

...was VP, chromatography and mass spectrometry, EMEA, at Thermo Fisher Scientific Inc. (NYSE:TMO). Immunology company Kezar Life Sciences Inc....

...NASDAQ:MGTA) 6/20/18 $100.0 $515.6 $459.2 -11% Xeris Pharmaceuticals Inc. (NASDAQ:XERS) 6/20/18 $98.3 $308.9 $380.9 23% Kezar Life Sciences Inc....

...start a Phase II study of the therapy to treat sickle cell disease. Immunology company Kezar Life Sciences Inc....
...Mass. Kezar Life Sciences Inc. (NASDAQ:KZR), South San Francisco, Calif. Xeris Pharmaceuticals Inc. (NASDAQ:XERS), Austin, Texas Paul Bonanos Aptinyx Inc. Avrobio Inc. Kezar Life Sciences Magenta...

...start a Phase II study of the therapy to treat sickle cell disease. Immunology company Kezar Life Sciences Inc....
...Glucagon Rescue Pen, which delivers glucagon via an auto-injector to treat severe hypoglycemia. Paul Bonanos Aptinyx Inc. Avrobio Inc. Kezar Life Sciences Magenta...

...last year led by Cormorant Asset Management and Morningside Ventures. Kezar Life Sciences Inc., South San Francisco, Calif. Allison Johnson KZR-616 Kezar Life Sciences...

...B round last year led by Cormorant Asset Management and Morningside Ventures. Allison Johnson KZR-616 Amgen Inc. Cormorant Asset Management Kezar Life Sciences Morningside...